ALIM

Alimera Sciences Stock Price

10.97
0.00 (0.0%)
10.97
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Alimera Sciences Inc ALIM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 10.97 07:32:54
Open Price Low Price High Price Close Price Prev Close
10.97
Bid Price Ask Price Spread News
10.76 13.00 2.24 - -
Trades Volume Avg Volume 52 Week Range
1 20 106,173 3.821 - 12.25
Last Trade Time Type Quantity Stock Price Currency
07:15:34 20 $ 10.98 USD

Alimera Sciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 62.74M 5.72M 5.16M $ 53.94M $ -3.59M -2.19 -10.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Alimera Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALIM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week9.7611.84999.13210.4279,9271.2112.4%
1 Month10.8112.259.13210.2272,5230.161.48%
3 Months7.8912.256.569.2591,8933.0839.04%
6 Months4.6012.253.8217.3178,8186.37138.48%
1 Year4.7912.253.8216.9755,9676.18129.02%
3 Years1.1412.250.00031.86133,6499.83862.28%
5 Years2.0012.250.00031.63229,6068.97448.5%

Alimera Sciences Description

Alimera Sciences is a pharmaceutical company focused on commercializing and developing treatments that address diseases affecting the back of the eye (retina). ILUVIEN(R) is Alimera's a patented micro-implant which delivers a continuous, low dose anti-inflammatory agent to the retina for up to 3 years. A $2B global market, DME is often treated with acute therapies when the fluid in the eye returns. ILUVIEN reduces the recurrence of edema leading to stable vision, with the benefit of continuous treatment due to the product's novel drug delivery technology.


Your Recent History
NASDAQ
ALIM
Alimera Sc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.